# Japanese Bridging Study Conducted in the United States

> **NCT00947245** · PHASE1 · WITHDRAWN · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Hepatitis C Virus

## Interventions

- **DRUG:** BMS-791325
- **DRUG:** BMS-791325
- **DRUG:** BMS-791325
- **DRUG:** BMS-791325
- **DRUG:** BMS-791325
- **DRUG:** BMS-791325
- **DRUG:** Placebo
- **DRUG:** Placebo
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00947245
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-10
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947245, "Japanese Bridging Study Conducted in the United States". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00947245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*